Tested Applications
| Positive WB detected in | A549 cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:2000 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
23902-1-AP targets RBM47 in WB, IP, RIP, ELISA applications and shows reactivity with human samples.
| Tested Reactivity | human |
| Cited Reactivity | human, mouse |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag20984 Product name: Recombinant human RBM47 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 444-593 aa of BC126261 Sequence: VAIPAIGAQYSMFPAAPAPKMIEDGKIHTVEHMISPIAVQPDPASAAAAAAAAAAAAAAVIPTVSTPPPFQGRPITPVYTVAPNVQRIPTAGIYGASYVPFAAPATATIATLQKNAAAAAAVYGGYAGYIPQAFPAAAIQVPIPDVYQTY Predict reactive species |
| Full Name | RNA binding motif protein 47 |
| Calculated Molecular Weight | 593 aa, 64 kDa |
| Observed Molecular Weight | 64 kDa |
| GenBank Accession Number | BC126261 |
| Gene Symbol | RBM47 |
| Gene ID (NCBI) | 54502 |
| RRID | AB_2879356 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen Affinity purified |
| UNIPROT ID | A0AV96 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Protocols
| Product Specific Protocols | |
|---|---|
| WB protocol for RBM47 antibody 23902-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The RBM47 Polyclonal antibody (Cat# 23902-1-AP) has 9 citations. Journals include Circulation, Cancer Research, Cell Death Discovery, Apoptosis, Biochemical Pharmacology, Communications Biology, International Immunopharmacology, Korean Journal of Physiology and Pharmacology, and BMC Nephrology. Research fields span atherosclerosis, ferroptosis, hepatocellular carcinoma, renal cell carcinoma, postoperative cognitive dysfunction, apolipoprotein B mRNA editing, and endothelial-to-mesenchymal transition in vascular biology.
| Species | Application | Title |
|---|---|---|
Circulation HELZ2 Regulates Apob mRNA Stability to Modulate Fatty Liver Disease and Atherosclerosis. | ||
Cancer Res TRAPPC4 Promotes GPX4 Stability to Drive Ferroptosis Resistance and Tumor Progression in Head and Neck Squamous Cell Carcinoma | ||
Cell Death Discov RBM47 inhibits hepatocellular carcinoma progression by targeting UPF1 as a DNA/RNA regulator.
| ||
Apoptosis Deubiquitinating enzyme OTUD4 stabilizes RBM47 to induce ATF3 transcription: a novel mechanism underlying the restrained malignant properties of ccRCC cells | ||
Biochem Pharmacol RNA-binding protein RBM47 enhances ENC1 stability through AU-rich elements to induce oxidative stress in macrophages in atherosclerosis progression.
| ||
Commun Biol Microglial RUNX1/RBM47 ablation inhibits neuronal ferroptosis via regulating the cGAS-STING-MEF2C pathway in mice with postoperative cognitive dysfunction.
|

